[Peritoneal mesothelioma: long survival with intraperitoneal chemotherapy, lanreotide and mucolytics]

Gastroenterol Clin Biol. 2008 Oct;32(10):874-5. doi: 10.1016/j.gcb.2007.11.010. Epub 2008 Mar 18.
[Article in French]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use*
  • Expectorants / therapeutic use*
  • Humans
  • Male
  • Mesothelioma / drug therapy*
  • Peptides, Cyclic / therapeutic use*
  • Peritoneal Neoplasms / drug therapy*
  • Peritoneum
  • Somatostatin / analogs & derivatives*
  • Somatostatin / therapeutic use
  • Survivors
  • Time Factors

Substances

  • Antineoplastic Agents
  • Expectorants
  • Peptides, Cyclic
  • lanreotide
  • Somatostatin